Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort

BACKGROUND: Fluoroquinolone is a commonly prescribed antimicrobial agent, and up to 20% of its users registers adverse gastroenterological symptoms. We aimed to evaluate the association between use of fluoroquinolone and gastrointestinal tract perforation. METHODS: We conducted a nested case-control...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Shou-Chien, Chang, Shy-Shin, Lee, Meng-tse Gabriel, Lee, Si-Huei, Tsai, Yi-Wen, Lin, Shen-Che, Chen, Szu-Ta, Weng, Yi-Chieh, Porta, Lorenzo, Wu, Jiunn-Yih, Lee, Chien-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584983/
https://www.ncbi.nlm.nih.gov/pubmed/28873440
http://dx.doi.org/10.1371/journal.pone.0183813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584983/
https://www.ncbi.nlm.nih.gov/pubmed/28873440
http://dx.doi.org/10.1371/journal.pone.0183813

Ejemplares similares